These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11322495)

  • 1. Do growth hormone-releasing peptides act as ghrelin secretagogues?
    Ahnfelt-Rønne I; Nowak J; Olsen UB
    Endocrine; 2001 Feb; 14(1):133-5. PubMed ID: 11322495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History to the discovery of ghrelin.
    Bowers CY
    Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
    Tannenbaum GS; Bowers CY
    Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor.
    García A; Alvarez CV; Smith RG; Diéguez C
    Mol Endocrinol; 2001 Sep; 15(9):1484-95. PubMed ID: 11518797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs.
    Bhatti SF; Duchateau L; Van Ham LM; De Vliegher SP; Mol JA; Rijnberk A; Kooistra HS
    Vet J; 2006 Nov; 172(3):515-25. PubMed ID: 15951209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription.
    Chan CB; Fung CK; Fung W; Tse MC; Cheng CH
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):77-85. PubMed ID: 15556068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH.
    Roh SG; Doconto M; Feng DD; Chen C
    Endocrine; 2006 Aug; 30(1):55-62. PubMed ID: 17185792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686.
    Nagamine J; Nagata R; Seki H; Nomura-Akimaru N; Ueki Y; Kumagai K; Taiji M; Noguchi H
    J Endocrinol; 2001 Dec; 171(3):481-9. PubMed ID: 11739014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipamorelin, the first selective growth hormone secretagogue.
    Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH
    Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats.
    Tamura H; Kamegai J; Shimizu T; Ishii S; Sugihara H; Oikawa S
    Endocrinology; 2002 Sep; 143(9):3268-75. PubMed ID: 12193538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of a new oral GH secretagogue, NN703.
    Hansen BS; Raun K; Nielsen KK; Johansen PB; Hansen TK; Peschke B; Lau J; Andersen PH; Ankersen M
    Eur J Endocrinol; 1999 Aug; 141(2):180-9. PubMed ID: 10427162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization.
    Wells T; Houston PA
    J Neuroendocrinol; 2001 Jun; 13(6):496-504. PubMed ID: 11412336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
    Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
    Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
    Lawrence CB; Snape AC; Baudoin FM; Luckman SM
    Endocrinology; 2002 Jan; 143(1):155-62. PubMed ID: 11751604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus.
    Bailey AR; Giles M; Brown CH; Bull PM; Macdonald LP; Smith LC; Smith RG; Leng G; Dickson SL
    Neuroendocrinology; 1999 Aug; 70(2):83-92. PubMed ID: 10461022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
    Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.